Clinical Trial: The Value of PET Imaging Targeting Granzyme B in Predicting Efficacy and Prognosis in T-NK Cell Lymphoma

U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06863441) titled 'The Value of PET Imaging Targeting Granzyme B in Predicting Efficacy and Prognosis in T-NK Cell Lymphoma' on Feb. 20.

Brief Summary: The study on the value of PET imaging targeting granzyme B in predicting the efficacy and prognosis of T-NK cell lymphoma.

Study Start Date: March 01

Study Type: OBSERVATIONAL

Condition: T-NK Cell Lymphoma

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Ruijin Hospital

Information provided by (Responsible Party): LI BIAO, Ruijin Hospital

Disclaimer: Curated by HT Syndication....